- Paul J. Diaz elected to Merck board effective Nov. 1, 2026.
Merck adds healthcare industry veteran Paul J. Diaz to its board, effective Nov. 1. Diaz brings CEO experience from Myriad Genetics and Kindred Healthcare. He will stand for shareholder election in May 2027.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.